MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in well-closed containers. Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Inegy 10mg/40mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 200mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 200mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 25mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 25mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aubagio 14mg tablets (Sanofi Genzyme).

Stability Notes

Protect from moisture in well-closed containers.

Provenance

Compatibility information derived from Loniten 10mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Macrobid 100mg modified-release capsules (Advanz Pharma).

Stability Notes

Protect from moisture and light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Lorazepam 1mg tablets (Genus Pharmaceuticals Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Malarone 250mg/100mg tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Protect from moisture and light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Lorazepam 2.5mg tablets (Genus Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.